More than a marker: potential pathogenic functions of MAP2
Open accessThe DOI matches its Crossref record; 179 of the 179 references it cites were found in a registry or an index.
Abstract
Microtubule-associated protein 2 (MAP2) is the predominant cytoskeletal regulator within neuronal dendrites, abundant and specific enough to serve as a robust somatodendritic marker. It influences microtubule dynamics and microtubule/actin interactions to control neurite outgrowth and synaptic functions, similarly to the closely related MAP Tau. Though pathology of Tau has been well appreciated in the context of neurodegenerative disorders, the consequences of pathologically dysregulated MAP2 have been little explored, despite alterations in its immunoreactivity, expression, splicing and/or stability being observed in a variety of neurodegenerative and neuropsychiatric disorders including Huntington’s disease, prion disease, schizophrenia, autism, major depression and bipolar disorder. Here we review the understood structure and functions of MAP2, including in neurite outgrowth, synaptic plasticity, and regulation of protein folding/transport. We also describe known and potential mechanisms by which MAP2 can be regulated via post-translational modification. Then, we assess existing evidence of its dysregulation in various brain disorders, including from immunohistochemical and (phospho) proteomic data. We propose pathways by which MAP2 pathology could contribute to endophenotypes which characterize these disorders, giving rise to the concept of a “MAP2opathy”—a series of disorders characterized by alterations in MAP2 function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
The mutational constraint spectrum quantified from variation in 141,456 humans
Karczewski, K. J., Francioli, L. C., Tiao, G., Cummings, B. B., Alföldi, J., Wang, Q., Collins, R. L., Laricchia, K. M., Ganna, A., Birnbaum, D. P., et al. (2020) · Nature · doi:10.1038/s41586-020-2308-7 · Cited by 9,434 · cited 1×
“1 (Karczewski et al., 2020)] and limit the ability of organisms to transmit MAP2 mutations that could later cause neuropathology.”
BackgroundBiological insights from 108 schizophrenia-associated genetic loci
Schizophrenia Working Group of the Psychiatric Genomics Consortium (2014) · Nature · doi:10.1038/nature13595 · Cited by 7,577
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70299-6 · Cited by 4,806
Mapping genomic loci implicates genes and synaptic biology in schizophrenia
Trubetskoy, V., Pardiñas, A. F., Qi, T., Panagiotaropoulou, G., Awasthi, S., Bigdeli, T. B., Bryois, J., Chen, C.-Y., Dennison, C. A., Hall, L. S., et al. (2022) · Nature · doi:10.1038/s41586-022-04434-5 · Cited by 2,964
Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade
Chiti, F., & Dobson, C. M. (2017) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-061516-045115 · Cited by 2,629 · cited 1×
“leads to their aggregation, giving rise to the amyloidoses, in which more than 37 distinct proteins have been implicated (Chiti and Dobson, 2017).”
BackgroundPrediction and Functional Analysis of Native Disorder in Proteins from the Three Kingdoms of Life
Ward, J. J., Sodhi, J. S., McGuffin, L. J., Buxton, B. F., & Jones, D. T. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.02.002 · Cited by 2,017
The mutational constraint spectrum quantified from variation in 141,456 humans
Karczewski, K. J., Francioli, L. C., Tiao, G., Cummings, B. B., Alföldi, J., Wang, Q., Collins, R. L., Laricchia, K. M., Ganna, A., Birnbaum, D. P., et al. (2019) · doi:10.1101/531210 · Cited by 1,662
Howe, K. L., Achuthan, P., Allen, J., Allen, J., Alvarez-Jarreta, J., Amode, M. R., Armean, I. M., Azov, A. G., Bennett, R., Bhai, J., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkaa942 · Cited by 1,568
Rajkowska, G., Miguel-Hidalgo, J. J., Wei, J., Dilley, G., Pittman, S. D., Meltzer, H. Y., Overholser, J. C., Roth, B. L., & Stockmeier, C. A. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00041-4 · Cited by 1,477
Psychiatric GWAS Consortium Bipolar Disorder Working Group, Sklar, P., Ripke, S., Scott, L. J., Andreassen, O. A., Cichon, S., Craddock, N., Edenberg, H. J., Nurnberger, J. I., Rietschel, M., et al. (2011) · Nature Genetics · doi:10.1038/ng.943 · Cited by 1,344
Transcriptome-wide isoform-level dysregulation in ASD, schizophrenia, and bipolar disorder
Gandal, M. J., Zhang, P., Hadjimichael, E., Walker, R. L., Chen, C., Liu, S., Won, H., van Bakel, H., Varghese, M., Wang, Y., et al. (2018) · Science · doi:10.1126/science.aat8127 · Cited by 1,247 · cited 2×
“Such change, however, is likely to originate post-transcriptionally, as mRNA levels appear to be unaltered (Gandal et al., 2018).”
BackgroundFlexible nets: The roles of intrinsic disorder in protein interaction networks
Dunker, A. K., Cortese, M. S., Romero, P., Iakoucheva, L. M., & Uversky, V. N. (2005) · The FEBS Journal · doi:10.1111/j.1742-4658.2005.04948.x · Cited by 1,122 · cited 1×
“The structurally fluid nature of IDPs, including Tau, makes them well suited to play roles in numerous, diverse signaling pathways (Dunker et al., 2005); thus, depending on the exact pathology, a range of pleiotropic effects can be observed in IDP pathogenesis.”
BackgroundBramblett, G. T., Goedert, M., Jakes, R., Merrick, S. E., Trojanowski, J. Q., & Lee, V. M. Y. (1993) · Neuron · doi:10.1016/0896-6273(93)90057-x · Cited by 903 · cited 3×
“Interestingly, this residue is homologous to S396 in Taua residue which is associated with AD and regulates Tau localization as well as LTD (Bramblett et al., 1993; MondragónRodríguez et al., 2014; Regan et al., 2015; Xia et al., 2015; Wesseling et al., 2020).”
BackgroundDecreased expression of synapse-related genes and loss of synapses in major depressive disorder
Kang, H. J., Voleti, B., Hajszan, T., Rajkowska, G., Stockmeier, C. A., Licznerski, P., Lepack, A., Majik, M. S., Jeong, L. S., Banasr, M., et al. (2012) · Nature Medicine · doi:10.1038/nm.2886 · Cited by 808 · cited 1×
“MAP2-IR reduction has additionally been reported in the DLPFC of individuals with major depressive disorder (Kang et al., 2012) and in the hippocampus of major depression and bipolar disorder subjects (Rosoklija et al.”
BackgroundSex-specific transcriptional signatures in human depression
Labonté, B., Engmann, O., Purushothaman, I., Menard, C., Wang, J., Tan, C., Scarpa, J. R., Moy, G., Loh, Y.-H. E., Cahill, M., et al. (2017) · Nature Medicine · doi:10.1038/nm.4386 · Cited by 748 · cited 1×
“However, a separate study utilizing RNA sequencing to study sex-specific transcriptomic changes in depression identified a male-specific reduction in MAP2 mRNA level in multiple cortical regions (Labonté et al., 2017).”
BackgroundTau PTM Profiles Identify Patient Heterogeneity and Stages of Alzheimer’s Disease
Wesseling, H., Mair, W., Kumar, M., Schlaffner, C. N., Tang, S., Beerepoot, P., Fatou, B., Guise, A. J., Cheng, L., Takeda, S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.10.029 · Cited by 688
Domains of tau Protein and Interactions with Microtubules
Gustke, N., Trinczek, B., Biernat, J., Mandelkow, E.-M., & Mandelkow, E. (1994) · Biochemistry · doi:10.1021/bi00198a017 · Cited by 655
Building the Neuronal Microtubule Cytoskeleton
Kapitein, L. C., & Hoogenraad, C. C. (2015) · Neuron · doi:10.1016/j.neuron.2015.05.046 · Cited by 650 · cited 1×
“In neurons, the MT network critically defines neurite morphology and mediates trafficking processes essential for synaptic transmission (Kapitein and Hoogenraad, 2015).”
BackgroundDynamic microtubules regulate dendritic spine morphology and synaptic plasticity
Jaworski, J., Kapitein, L. C., Gouveia, S. M., Dortland, B. R., Wulf, P. S., Grigoriev, I., Camera, P., Spangler, S. A., Di Stefano, P., Demmers, J., et al. (2009) · Neuron · doi:10.1016/j.neuron.2008.11.013 · Cited by 643
Projection domains of MAP2 and tau determine spacings between microtubules in dendrites and axons
Chen, J., Kanai, Y., Cowan, N. J., & Hirokawa, N. (1992) · Nature · doi:10.1038/360674a0 · Cited by 601 · cited 1×
“In contrast, the projection domain appears to regulate MT spacing (Chen et al., 1992).”
BackgroundDendritic spine pathology in schizophrenia
Glausier, J. R., & Lewis, D. A. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2012.04.044 · Cited by 581
Microtubules and Microtubule-Associated Proteins
Goodson, H. V., & Jonasson, E. M. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022608 · Cited by 579 · cited 1×
“MTs, comprised of heterodimers of α- and β-tubulin subunits, are present in all cell types and provide dynamic support to enable cell migration/division, modify and maintain cellular shape, and serve as tracks for intracellular trafficking (Goodson and Jonasson, 2018).”
BackgroundSelective localization of messenger RNA for cytoskeletal protein MAP2 in dendrites
Garner, C. C., Tucker, R. P., & Matus, A. (1988) · Nature · doi:10.1038/336674a0 · Cited by 558 · cited 1×
“Following transcription, MAP2 mRNA localizes to neuronal dendrites for local translation (Garner et al., 1988).”
Akt/GSK3 Signaling in the Action of Psychotropic Drugs
Beaulieu, J.-M., Gainetdinov, R. R., & Caron, M. G. (2009) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.011008.145634 · Cited by 522 · cited 1×
“It is also thought to be a major effective target of various antipsychotics, antidepressants and mood stabilizers such as lithium (Beaulieu et al., 2009).”
BackgroundSánchez, C. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00046-5 · Cited by 511
Microtubule-Associated Protein MAP2 Shares a Microtubule Binding Motif with Tau Protein
Lewis, S. A., Wang, D. H., & Cowan, N. J. (1988) · Science · doi:10.1126/science.3142041 · Cited by 483 · cited 12×
“Expression of antisense oligonucleotides against MAP2 reduces the number of neurites and MTs within neurites in primary cortical cultures (Sharma et al., 1994).”
BackgroundInfluentialRomero, P. R., Zaidi, S., Fang, Y. Y., Uversky, V. N., Radivojac, P., Oldfield, C. J., Cortese, M. S., Sickmeier, M., LeGall, T., Obradovic, Z., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507916103 · Cited by 480
The importance of tau phosphorylation for neurodegenerative diseases
Noble, W., Hanger, D. P., Miller, C. C. J., & Lovestone, S. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00083 · Cited by 475 · cited 8×
“MAP2 phosphorylation events observed in NFTs also have yet to be modeled, which could be used to illuminate what roles—if any—MAP2 phosphorylation plays in Tau aggregation/pathology.”
BackgroundInfluentialTight Regulation of Unstructured Proteins: From Transcript Synthesis to Protein Degradation
Gsponer, J., Futschik, M. E., Teichmann, S. A., & Babu, M. M. (2008) · Science · doi:10.1126/science.1163581 · Cited by 466 · cited 1×
“, 2006), and tend to have relatively low rates of synthesis and short half-lives (Gsponer et al., 2008),”
BackgroundOstroff, L. E., Fiala, J. C., Allwardt, B., & Harris, K. M. (2002) · Neuron · doi:10.1016/s0896-6273(02)00785-7 · Cited by 461 · cited 1×
“MAP2 creates local dendritic reservoirs of proteins critical to LTP/LTD, including PKA, EB3, RNA particles and polyribosomes (Lim and Halpain, 2000; Nielsen et al., 2002; Ostroff et al., 2002; Angenstein et al., 2005; Farah et al., 2005; Zhong et al., 2009; Kapitein et al., 2011; Sontag et al., 2012; Chirillo et al.,…”
BackgroundAlonso, A. D. C., Grundke-Iqbal, I., Barra, H. S., & Iqbal, K. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.1.298 · Cited by 437
MAPT mutations, tauopathy, and mechanisms of neurodegeneration
Strang, K. H., Golde, T. E., & Giasson, B. I. (2019) · Laboratory Investigation · doi:10.1038/s41374-019-0197-x · Cited by 424 · cited 1×
“Mutation of the encoding gene is associated with disease Mutations in MAPT gene lead to FTDP-17 as well as other neurodegenerative disorders similar to Pick’s disease, corticobasal degeneration and supranuclear palsy (Strang et al., 2019) Autism-associated rare 2q34 microdeletions encompass the MAP2 gene (Pescucci et…”
BackgroundAnkyrinG is required for maintenance of the axon initial segment and neuronal polarity
Hedstrom, K. L., Ogawa, Y., & Rasband, M. N. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200806112 · Cited by 371
Harada, A., Teng, J., Takei, Y., Oguchi, K., & Hirokawa, N. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200110134 · Cited by 366
Microtubule-Associated Proteins: Structuring the Cytoskeleton
Bodakuntla, S., Jijumon, A. S., Villablanca, C., Gonzalez-Billault, C., & Janke, C. (2019) · Trends in Cell Biology · doi:10.1016/j.tcb.2019.07.004 · Cited by 366 · cited 1×
“Among these, the microtubule-associated proteins (MAPs) define a set of proteins which directly bind MTs, typically serving to stabilize them (Bodakuntla et al., 2019).”
BackgroundCaceres, A., Binder, L., Payne, M., Bender, P., Rebhun, L., & Steward, O. (1984) · The Journal of Neuroscience · doi:10.1523/jneurosci.04-02-00394.1984 · Cited by 352 · cited 1×
“Whereas the subcellular localization of Tau is predominantly axonal (although some Tau has been observed in dendrites and dendritic spines), MAP2 are predominantly somatodendritic (Caceres et al., 1984), although MAP2C can be detected in axons (Meichsner et al.”
BackgroundPejaver, V., Hsu, W., Xin, F., Dunker, A. K., Uversky, V. N., & Radivojac, P. (2014) · Protein Science · doi:10.1002/pro.2494 · Cited by 349
HERZOG, W., & WEBER, K. (1978) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1978.tb12716.x · Cited by 310
Teng, J., Takei, Y., Harada, A., Nakata, T., Chen, J., & Hirokawa, N. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200106025 · Cited by 305
Velikonja, T., Fett, A.-K., & Velthorst, E. (2019) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.3645 · Cited by 292
Activity-Dependent Dynamic Microtubule Invasion of Dendritic Spines
Hu, X., Viesselmann, C., Nam, S., Merriam, E., & Dent, E. W. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3074-08.2008 · Cited by 290
Lewis, S. A., Ivanov, I. E., Lee, G.-H., & Cowan, N. J. (1989) · Nature · doi:10.1038/342498a0 · Cited by 288 · cited 1×
“It has been long accepted that the primary function of MAP2, like Tau, is to bind MTs to increase their polymerization and bundling (Herzog and Weber, 1978; Stearns and Brown, 1979; Lewis et al., 1989).”
BackgroundMondragón‐Rodríguez, S., Perry, G., Luna‐Muñoz, J., Acevedo‐Aquino, M. C., & Williams, S. (2014) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12084 · Cited by 275
Opposite Molecular Signatures of Depression in Men and Women
Seney, M. L., Huo, Z., Cahill, K., French, L., Puralewski, R., Zhang, J., Logan, R. W., Tseng, G., Lewis, D. A., & Sibille, E. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.01.017 · Cited by 272 · cited 1×
“In contrast, microarray data indicates no change in MAP2 mRNA expression in depression (Seney et al., 2018).”
ResultTau PET in Alzheimer disease and mild cognitive impairment
Cho, H., Choi, J. Y., Hwang, M. S., Lee, J. H., Kim, Y. J., Lee, H. M., Lyoo, C. H., Ryu, Y. H., & Lee, M. S. (2016) · Neurology · doi:10.1212/wnl.0000000000002892 · Cited by 270 · cited 1×
“Degree of protein dysregulation scales with disease pathology Burden of tau PET binding correlates with cognitive symptoms and severity of regional atrophy (Cho et al., 2016).”
BackgroundDeshpande, J., Bergstedt, K., Lindén, T., Kalimo, H., & Wieloch, T. (1992) · Experimental Brain Research · doi:10.1007/bf02259131 · Cited by 262
Single-molecule investigation of the interference between kinesin, tau and MAP2c
Seitz, A., Kojima, H., Oiwa, K., Mandelkow, E.-M., Song, Y.-H., & Mandelkow, E. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf503 · Cited by 257 · cited 1×
“MAP2 also regulates protein transport, predominantly by steric inhibition of the MT motors kinesin and dynein (Lopez and Sheetz, 1993; Hagiwara et al., 1994; Seitz et al., 2002).”
BackgroundMartínez‐Cerdeño, V. (2017) · Developmental Neurobiology · doi:10.1002/dneu.22417 · Cited by 256 · cited 1×
“Additionally, in postmortem brain tissue from individuals with autism, dendritic spine morphology shifts towards more immature phenotypes (Martínez-Cerdeño, 2017), which could result from a lack of MAP2-mediated activity-dependent spine growth.”
BackgroundGong, R., Park, C. S., Abbassi, N. R., & Tang, S.-J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512524200 · Cited by 249 · cited 1×
“This may be mediated by mTOR signaling, as rapamycin blocks tetanusinduced dendritic synthesis of MAP2 protein in hippocampal slice (Gong et al., 2006).”
BackgroundSignaling Mechanisms Underlying Reversible, Activity-Dependent Dendrite Formation
Vaillant, A. R., Zanassi, P., Walsh, G. S., Aumont, A., Alonso, A., & Miller, F. D. (2002) · Neuron · doi:10.1016/s0896-6273(02)00717-1 · Cited by 242
Arnold, S. E., Lee, V. M., Gur, R. E., & Trojanowski, J. Q. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10850 · Cited by 236 · cited 1×
“This observation has been made in the subiculum, the olfactory bulbs, entorhinal cortex, BA9, BA32 and, in our studies, dorsolateral prefrontal cortex (DLPFC), lateral intraparietal cortex, primary visual cortex, and primary auditory cortex (BA41; Arnold et al., 1991; Jones et al., 2002; Rioux et al., 2004; Rosoklija…”
BackgroundSoluble forms of tau are toxic in Alzheimer's disease
Kopeikina, K., Hyman, B., & Spires-Jones, T. (2012) · Translational Neuroscience · doi:10.2478/s13380-012-0032-y · Cited by 232
Pivotal role of glycogen synthase kinase-3: A therapeutic target for Alzheimer's disease
Maqbool, M., Mobashir, M., & Hoda, N. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.10.018 · Cited by 227 · cited 1×
“GSK-3β, another kinase of MAP2, is a major regulator of neuronal development and has been strongly implicated in Alzheimer’s disease (Maqbool et al., 2016).”
BackgroundMicrotubules in Dendritic Spine Development
Gu, J., Firestein, B. L., & Zheng, J. Q. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2509-08.2008 · Cited by 219 · cited 1×
“The role of MT dynamics in mediating the structural and functional plasticity of dendritic spines has become well-appreciated following the discovery that MTs transiently invade spines in an activity-dependent manner (Gu et al., 2008; Hu et al., 2008; Mitsuyama et al., 2008; Jaworski et al., 2009).”
BackgroundLefebvre, T., Ferreira, S., Dupont-Wallois, L., Bussière, T., Dupire, M.-J., Delacourte, A., Michalski, J.-C., & Caillet-Boudin, M.-L. (2003) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(02)00477-4 · Cited by 209 · cited 1×
“Similarly, Tau is significantly less O-GlcNAc glycosylated when hyperphosphorylated (Lefebvre et al., 2003; Robertson et al., 2004).”
BackgroundPucilowska, J., Vithayathil, J., Tavares, E. J., Kelly, C., Karlo, J. C., & Landreth, G. E. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.4864-13.2015 · Cited by 207
Tau Phosphorylation at Serine 396 Residue Is Required for Hippocampal LTD
Regan, P., Piers, T., Yi, J.-H., Kim, D.-H., Huh, S., Park, S. J., Ryu, J. H., Whitcomb, D. J., & Cho, K. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.2842-14.2015 · Cited by 202
Gumy, L. F., Katrukha, E. A., Grigoriev, I., Jaarsma, D., Kapitein, L. C., Akhmanova, A., & Hoogenraad, C. C. (2017) · Neuron · doi:10.1016/j.neuron.2017.03.046 · Cited by 186
Synaptic Regulation of Microtubule Dynamics in Dendritic Spines by Calcium, F-Actin, and Drebrin
Merriam, E. B., Millette, M., Lumbard, D. C., Saengsawang, W., Fothergill, T., Hu, X., Ferhat, L., & Dent, E. W. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.0661-13.2013 · Cited by 179 · cited 1×
“Recent studies have also illuminated the importance of MT-actin crosstalk to spine morphogenesis, with actin remodeling at activated spines promoting MT entry (Merriam et al., 2013; Schätzle et al., 2018), although to date it is unknown if the MT-actin crosslinking function of MAP2 plays a role in this process.”
BackgroundDawson, D. A., & Hallenbeck, J. M. (1996) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199601000-00020 · Cited by 177 · cited 1×
“MAP2 expression is significantly and consistently reduced early after induction of ischemia in both rodents (Dawson and Hallenbeck, 1996; Mages et al., 2021) and humans (Kühn et al.”
BackgroundDehmelt, L., Smart, F. M., Ozer, R. S., & Halpain, S. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-29-09479.2003 · Cited by 172 · cited 2×
“Despite clear evidence that disruptions to MAP2 expression and/or modification can lead to changes in dendritic and synaptic structure and function (Sharma et al., 1994; Ozer and Halpain, 2000; Harada et al., 2002; Akulinin and Dahlstrom, 2003; Dehmelt et al., 2003; Huang et al., 2013; Kim et al., 2020; Grubisha et al…”
BackgroundIdentification of a cis-Acting Dendritic Targeting Element in MAP2 mRNAs
Blichenberg, A., Schwanke, B., Rehbein, M., Garner, C. C., Richter, D., & Kindler, S. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-20-08818.1999 · Cited by 171 · cited 1×
“In rat neurons, translocation of this mRNA is dependent upon the trans-acting protein MARTA2—which has high affinity for a cis-acting 3’ UTR dendritic targeting element (Blichenberg et al., 1999)—as well as the kinesin KIF5 (Rehbein et al.”
BackgroundMarx, C. E., Bradford, D. W., Hamer, R. M., Naylor, J. C., Allen, T. B., Lieberman, J. A., Strauss, J. L., & Kilts, J. D. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.06.076 · Cited by 160
Springer, J. E., Azbill, R. D., Kennedy, S. E., George, J., & Geddes, J. W. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69041592.x · Cited by 150 · cited 1×
“Interestingly, this parallels findings from brain injury models, such as ischemia and traumatic spinal cord injury, which also describe calpain-mediated MAP2 degradation (Pettigrew et al., 1996; Springer et al., 1997).”
BackgroundLaw, A. J., Weickert, C. S., Hyde, T. M., Kleinman, J. E., & Harrison, P. J. (2004) · American Journal of Psychiatry · doi:10.1176/ajp.161.10.1848 · Cited by 149 · cited 1×
“Moreover, MAP2 mRNA levels are unchanged in the hippocampal formation in schizophrenia subjects (Law et al., 2004).”
BackgroundDavare, M. A., Dong, F., Rubin, C. S., & Hell, J. W. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.42.30280 · Cited by 148 · cited 1×
“PKA, a binding partner and kinase of MAP2, acts downstream of voltage-gated calcium channels (Davare et al., 1999), which are now clearly identified by unbiased genomic studies as contributing to risk in schizophrenia, bipolar disorder, depression, and autism”
BackgroundKanai, Y., & Hirokawa, N. (1995) · Neuron · doi:10.1016/0896-6273(95)90298-8 · Cited by 144 · cited 1×
“An enhanced selectivity of the HMW forms for the dendritic compartment may be due to presence of the projection domain, which inhibits MAP2A/B access to axons (Kanai and Hirokawa, 1995), perhaps via interactions with axonal initial segment proteins such as AnkyrinG (Hedstrom et al.”
BackgroundCorreas, I., Padilla, R., & Avila, J. (1990) · Biochemical Journal · doi:10.1042/bj2690061 · Cited by 144 · cited 1×
“In addition to MTs, MAP2 can also bind and bundle actin, like Tau (Correas et al., 1990; Moraga et al., 1993; Roger et al., 2004).”
BackgroundMicrotubule and microtubule associated protein anomalies in psychiatric disease
Marchisella, F., Coffey, E. T., & Hollós, P. (2016) · Cytoskeleton · doi:10.1002/cm.21300 · Cited by 141 · cited 1×
“Reduced MAP2 immunoreactivity (MAP2-IR) has been reported in diverse brain regions in schizophrenia and has been described as a “molecular hallmark” of the disorder (Marchisella et al., 2016).”
BackgroundSubcellular Dynamics of Type II PKA in Neurons
Zhong, H., Sia, G.-M., Sato, T., Gray, N. W., Mao, T., Khuchua, Z. A., Huganir, R. L., & Svoboda, K. (2009) · Neuron · doi:10.1016/j.neuron.2009.03.013 · Cited by 138
Microtubular Proteolysis in Focal Cerebral Ischemia
Pettigrew, L. C., Holtz, M. L., Craddock, S. D., Minger, S. L., Hall, N. C., & Geddes, J. W. (1996) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199611000-00013 · Cited by 138 · cited 3×
“For instance, ischemia leads to calpain-induced MAP2 cleavage which is thought to disrupt cytoskeletal integrity and may contribute to neuronal atrophy (Pettigrew et al., 1996).”
BackgroundPregnenolone binds to microtubule-associated protein 2 and stimulates microtubule assembly
Murakami, K., Fellous, A., Baulieu, E.-E., & Robel, P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3579 · Cited by 133 · cited 1×
“, 2011, 2014)—enhances neurite growth by binding directly to MAP2 to simulate tubulin polymerization (Murakami et al., 2000; Fontaine-Lenoir et al., 2006).”
BackgroundOzer, R. S., & Halpain, S. (2000) · Molecular Biology of the Cell · doi:10.1091/mbc.11.10.3573 · Cited by 127 · cited 14×
“Expression of antisense oligonucleotides against MAP2 reduces the number of neurites and MTs within neurites in primary cortical cultures (Sharma et al., 1994).”
BackgroundInfluentialBaas, P. W., & Qiang, L. (2019) · Trends in Cell Biology · doi:10.1016/j.tcb.2019.02.007 · Cited by 123 · cited 1×
“This mechanism of MAP2 (and Tau; Baas and Qiang, 2019) can be thought of as a “dynamicspreserving” stabilization, as opposed to that of the “genuine” stabilizer MAP6, knockdown of which increases MT dynamics in the axonal compartment (Tortosa et al.”
BackgroundMicrotubule-associated protein 2 (MAP2) is a neurosteroid receptor
Fontaine-Lenoir, V., Chambraud, B., Fellous, A., David, S., Duchossoy, Y., Baulieu, E.-E., & Robel, P. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600113103 · Cited by 123 · cited 1×
“, 2011, 2014)—enhances neurite growth by binding directly to MAP2 to simulate tubulin polymerization (Murakami et al., 2000; Fontaine-Lenoir et al., 2006).”
BackgroundTortosa, E., Adolfs, Y., Fukata, M., Pasterkamp, R. J., Kapitein, L. C., & Hoogenraad, C. C. (2017) · Neuron · doi:10.1016/j.neuron.2017.04.042 · Cited by 122
Rudrabhatla, P., Jaffe, H., & Pant, H. C. (2011) · The FASEB Journal · doi:10.1096/fj.11-181297 · Cited by 121
Knock-out and transgenic mouse models of tauopathies
Denk, F., & Wade-Martins, R. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.05.010 · Cited by 120 · cited 1×
“Experimental manipulation of the protein causes disease-associated pathology Mutant Tau mouse lines such as rTg4150 can replicate key features of tauopathy including neuron loss and memory impairments (Denk and Wade-Martins, 2009).”
BackgroundNMDA Receptor Activation Suppresses Microtubule Growth and Spine Entry
Kapitein, L. C., Yau, K. W., Gouveia, S. M., van der Zwan, W. A., Wulf, P. S., Keijzer, N., Demmers, J., Jaworski, J., Akhmanova, A., & Hoogenraad, C. C. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.6215-10.2011 · Cited by 118
Actin depolymerisation induces process formation on MAP2-transfected non-neuronal cells
Edson, K., Weisshaar, B., & Matus, A. (1993) · Development · doi:10.1242/dev.117.2.689 · Cited by 118
Fifre, A., Sponne, I., Koziel, V., Kriem, B., Potin, F. T. Y., Bihain, B. E., Olivier, J.-L., Oster, T., & Pillot, T. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m507378200 · Cited by 117 · cited 1×
“Aβ oligomers can similarly induce such degradation (Fifre et al., 2006).”
BackgroundCytoplasmic trafficking of IGF-II mRNA-binding protein by conserved KH domains
Nielsen, F. C., Nielsen, J., Kristensen, M. A., Koch, G., & Christiansen, J. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.10.2087 · Cited by 117
Steric inhibition of cytoplasmic dynein and kinesin motility by MAP2
Lopez, L. A., & Sheetz, M. P. (1993) · Cell Motility · doi:10.1002/cm.970240102 · Cited by 115 · cited 1×
“MAP2 also regulates protein transport, predominantly by steric inhibition of the MT motors kinesin and dynein (Lopez and Sheetz, 1993; Hagiwara et al., 1994; Seitz et al., 2002).”
BackgroundMukaetova‐Ladinska, E. B., Arnold, H., Jaros, E., Perry, R., & Perry, E. (2004) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2004.00574.x · Cited by 115 · cited 1×
“In several case reports of intellectual disability and autism, reduced numbers of MAP2-IR+ neurons and dendrites has been noted, without a change in total neuron number (Kaufmann et al., 1995; Mukaetova-Ladinska et al., 2004).”
BackgroundHagiwara, H., Yorifuji, H., Sato-Yoshitake, R., & Hirokawa, N. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41903-x · Cited by 115
Di, J., Cohen, L. S., Corbo, C. P., Phillips, G. R., El Idrissi, A., & Alonso, A. D. (2016) · Scientific Reports · doi:10.1038/srep20833 · Cited by 113 · cited 1×
“Phosphomimicry of Tau can lead to learning and memory deficits in Drosophila and mice (Beharry et al., 2013; Di et al., 2016) MAP2 knockdown can lead to impairments in LTP and dendritic outgrowth, which are implicated in neurodevelopmental and neurodegenerative disorder (Kim et al.”
BackgroundMicrotubule-associated proteins as direct crosslinkers of actin filaments and microtubules
Mohan, R., & John, A. (2015) · IUBMB Life · doi:10.1002/iub.1384 · Cited by 112 · cited 1×
“Thus, both proteins act as cross-linkers between the MT and actin networks (Mohan and John, 2015).”
BackgroundMorales, M., & Fifkova´, E. (1989) · Cell and Tissue Research · doi:10.1007/bf00225592 · Cited by 112 · cited 1×
“In addition to the dendritic shaft, MAP2 has also been observed in dendritic spines as early as 1989 by immunogold electron microscopy (Morales and Fifkova, 1989), though it is found less abundantly in spines in the absence of synaptic stimulus (see Section “Synaptic plasticity”).”
BackgroundUversky, V. N. (2014) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2014.00006 · Cited by 112 · cited 1×
“The “IDPopathies” encompass a large group of human disorders which include various cancers, neurodegenerative diseases, diabetes, and cardiovascular disease (Uversky, 2014).”
BackgroundDisruption of MAP-2 Immunostaining in Rat Hippocampus After Traumatic Brain Injury
FOLKERTS, M. M., BERMAN, R. F., MUIZELAAR, J. P., & RAFOLS, J. A. (1998) · Journal of Neurotrauma · doi:10.1089/neu.1998.15.349 · Cited by 111 · cited 1×
“Moreover, MAP2 loss can be observed in regions of minimal cell death in mild traumatic brain injury models (Folkerts et al., 1998).”
BackgroundMAP2c, but Not Tau, Binds and Bundles F-Actin via Its Microtubule Binding Domain
Roger, B., Al-Bassam, J., Dehmelt, L., Milligan, R. A., & Halpain, S. (2004) · Current Biology · doi:10.1016/j.cub.2004.01.058 · Cited by 110
Support for calcium channel gene defects in autism spectrum disorders
Lu, A. T.-H., Dai, X., Martínez-Agosto, J. A., & Cantor, R. M. (2012) · Molecular Autism · doi:10.1186/2040-2392-3-18 · Cited by 109
Shelton, M. A., Newman, J. T., Gu, H., Sampson, A. R., Fish, K. N., MacDonald, M. L., Moyer, C. E., DiBitetto, J. V., Dorph-Petersen, K.-A., Penzes, P., et al. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.12.029 · Cited by 105
Self-citationLi, J., Wilkinson, B., Clementel, V. A., Hou, J., O’Dell, T. J., & Coba, M. P. (2016) · Science Signaling · doi:10.1126/scisignal.aaf6716 · Cited by 100 · cited 1×
“Moreover, long-standing findings have established that MAP2 is also phosphorylated in response to synaptic activity that induces plasticity (Quinlan and Halpain, 1996; Li et al., 2016).”
BackgroundThe potential role of tau protein O-glycosylation in Alzheimer's disease
Robertson, L. A., Moya, K. L., & Breen, K. C. (2004) · Journal of Alzheimer's Disease · doi:10.3233/jad-2004-6505 · Cited by 99
Tau mis-splicing in the pathogenesis of neurodegenerative disorders
Park, S. A., Ahn, S. I., & Gallo, J.-M. (2016) · BMB Reports · doi:10.5483/bmbrep.2016.49.8.084 · Cited by 96 · cited 1×
“Missplicing of Tau pre-mRNA- in some cases associated with MAPT mutation- is also associated with various tauopathies (Park et al., 2016) Changes in expression, post-translational modification and/or splicing of MAP2 have been described in various disorders (see Table 1)”
BackgroundSteward, O., & Halpain, S. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-18-07834.1999 · Cited by 93 · cited 1×
“Evidence suggests that local MAP2 protein translation in dendrites can be activity-dependent; prolonged high-frequency stimulation of the middle molecular layer of rat dentate gyrus causes an increase in MAP2 immunoreactivity in surrounding lamina, which is diminished by inhibition of protein synthesis (Steward and Ha…”
BackgroundChirillo, M. A., Waters, M. S., Lindsey, L. F., Bourne, J. N., & Harris, K. M. (2019) · Scientific Reports · doi:10.1038/s41598-019-40520-x · Cited by 92 · cited 1×
“MAP2 creates local dendritic reservoirs of proteins critical to LTP/LTD, including PKA, EB3, RNA particles and polyribosomes (Lim and Halpain, 2000; Nielsen et al., 2002; Ostroff et al., 2002; Angenstein et al., 2005; Farah et al., 2005; Zhong et al., 2009; Kapitein et al., 2011; Sontag et al., 2012; Chirillo et al.,…”
BackgroundDoll, T., Meichsner, M., Riederer, B. M., Honegger, P., & Matus, A. (1993) · Journal of Cell Science · doi:10.1242/jcs.106.2.633 · Cited by 90
Quinlan, E. M., & Halpain, S. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-23-07627.1996 · Cited by 90
Xia, D., Li, C., & Götz, J. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.12.017 · Cited by 89
Sotrel, A., Williams, R. S., Kaufmann, W. E., & Myers, R. H. (1993) · Neurology · doi:10.1212/wnl.43.10.2088 · Cited by 88 · cited 1×
“Thus, the shift towards LMW MAP2 could be expected to yield more dendrites, and indeed this has been reported in prefrontal cortex of a small cohort of Huntington’s subjects (Sotrel et al., 1993).”
BackgroundLim, R. W. L., & Halpain, S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001887200 · Cited by 86
Dynamic Microtubules Promote Synaptic NMDA Receptor-Dependent Spine Enlargement
Merriam, E. B., Lumbard, D. C., Viesselmann, C., Ballweg, J., Stevenson, M., Pietila, L., Hu, X., & Dent, E. W. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027688 · Cited by 82
Modulation of neurite branching by protein phosphorylation in cultured rat hippocampal neurons
Audesirk, G. J., Cabell, L., & Kern, M. (1997) · Developmental Brain Research · doi:10.1016/s0165-3806(97)00100-4 · Cited by 80 · cited 1×
“This observation was soon after substantiated by data indicating that treatment with protein kinase inhibitors reduces dendritic branching in these cells, while protein phosphatase inhibitors increase branching (Audesirk et al., 1997).”
ResultAbnormal Expression of Microtubule-Associated Protein 2 (MAP-2) in Neocortex in Rett Syndrome
Kaufmann, W., Naidu, S., & Budden, S. (1995) · Neuropediatrics · doi:10.1055/s-2007-979738 · Cited by 77 · cited 1×
“In several case reports of intellectual disability and autism, reduced numbers of MAP2-IR+ neurons and dendrites has been noted, without a change in total neuron number (Kaufmann et al., 1995; Mukaetova-Ladinska et al., 2004).”
BackgroundLeal, G., Comprido, D., Luca, P. D., de Morais, E. C. C., Rodrigues, L., Mele, M., Santos, A. R., Costa, R. O., Pinto, M. J., Patil, S. S., et al. (2017) · eNeuro · doi:10.1523/eneuro.0268-17.2017 · Cited by 77 · cited 1×
“Such proteins included FMR1, PCBP1–3, and hnRNPK, which has been previously shown to regulate spine density and LTP as well as mediate the effects of BDNF on dendritic mRNA metabolism and NMDAR function (Folci et al., 2014; Leal et al., 2017).”
BackgroundSontag, J.-M., Nunbhakdi-Craig, V., White, C. L., Halpain, S., & Sontag, E. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.338681 · Cited by 75 · cited 1×
“MAP2 creates local dendritic reservoirs of proteins critical to LTP/LTD, including PKA, EB3, RNA particles and polyribosomes (Lim and Halpain, 2000; Nielsen et al., 2002; Ostroff et al., 2002; Angenstein et al., 2005; Farah et al., 2005; Zhong et al., 2009; Kapitein et al., 2011; Sontag et al., 2012; Chirillo et al.,…”
BackgroundActivity-Dependent Actin Remodeling at the Base of Dendritic Spines Promotes Microtubule Entry
Schätzle, P., Esteves da Silva, M., Tas, R. P., Katrukha, E. A., Hu, H. Y., Wierenga, C. J., Kapitein, L. C., & Hoogenraad, C. C. (2018) · Current Biology · doi:10.1016/j.cub.2018.05.004 · Cited by 75
McVicker, D. P., Awe, A. M., Richters, K. E., Wilson, R. L., Cowdrey, D. A., Hu, X., Chapman, E. R., & Dent, E. W. (2016) · Nature Communications · doi:10.1038/ncomms12741 · Cited by 74 · cited 1×
“, 2011), delivering cargo to the spine head in response to synaptic activity (McVicker et al., 2016).”
BackgroundAlterations in MAP2 immunocytochemistry in areas 9 and 32 of schizophrenic prefrontal cortex
Jones, L. B., Johnson, N., & Byne, W. M. (2002) · Psychiatry Research Neuroimaging · doi:10.1016/s0925-4927(02)00022-7 · Cited by 73 · cited 2×
“The reduced MAP2-IR does not appear to result from reductions in neuron number/density, as this remains unchanged in areas where MAP2-IR loss is profound (Jones et al., 2002; Dorph-Petersen et al., 2009; Somenarain and Jones, 2010).”
BackgroundProof-of-concept randomized controlled trial of pregnenolone in schizophrenia
Marx, C. E., Lee, J., Subramaniam, M., Rapisarda, A., Bautista, D., Chan, E. S., Kilts, J. D., Buchanan, R. W., Eu, P. W., Verma, S. K., et al. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3673-4 · Cited by 73
Changes of MAP2 phosphorylation during brain development.
Riederer, B. M., Dráberová, E., Viklický, V., & Dráber, P. (1995) · Journal of Histochemistry & Cytochemistry · doi:10.1177/43.12.8537643 · Cited by 73
Martins-de-Souza, D., Guest, P. C., Vanattou-Saifoudine, N., Rahmoune, H., & Bahn, S. (2012) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-012-0301-3 · Cited by 71 · cited 1×
“83) in DLPFC of individuals with major depression, though these changes did not remain significant after controlling for false discovery rate (Martins-de-Souza et al., 2012).”
BackgroundSequence analysis of MAP2 function in living cells
Ferralli, J., Doll, T., & Matus, A. I. (1994) · Journal of Cell Science · doi:10.1242/jcs.107.11.3115 · Cited by 70
Microtubule‐associated protein 2 mediates induction of long‐term potentiation in hippocampal neurons
Kim, Y., Jang, Y., Kim, J. S., Kim, N., Noh, S., Kim, H., Queenan, B. N., Bellmore, R., Mun, J. Y., Park, H., et al. (2020) · The FASEB Journal · doi:10.1096/fj.201902122rr · Cited by 69 · cited 15×
“Additionally, they appear to differ in their ability to support activity-dependent spine plasticity, with HMW forms selectively translocating into spines following chemical LTP stimulus (Kim et al., 2020).”
BackgroundInfluentialSeo, M. K., Lee, C. H., Cho, H. Y., Lee, J. G., Lee, B. J., Kim, J. E., Seol, W., Kim, Y. H., & Park, S. W. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.11.019 · Cited by 68
Rehbein, M., Kindler, S., Horke, S., & Richter, D. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00114-5 · Cited by 67
High Molecular Weight Microtubule-associated Proteins Contain O-Linked N-Acetylglucosamine
Ding, M., & Vandré, D. D. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.21.12555 · Cited by 64
Cognitive decline associated with pathological burden in primary age‐related tauopathy
Jefferson‐George, K. S., Wolk, D. A., Lee, E. B., & McMillan, C. T. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.01.028 · Cited by 64
Sharma, N., Kress, Y., & Shafit‐Zagardo, B. (1994) · Cell Motility · doi:10.1002/cm.970270305 · Cited by 62 · cited 2×
“Despite clear evidence that disruptions to MAP2 expression and/or modification can lead to changes in dendritic and synaptic structure and function (Sharma et al., 1994; Ozer and Halpain, 2000; Harada et al., 2002; Akulinin and Dahlstrom, 2003; Dehmelt et al., 2003; Huang et al., 2013; Kim et al., 2020; Grubisha et al…”
BackgroundPyramidal neuron number in layer 3 of primary auditory cortex of subjects with schizophrenia
Dorph‐Petersen, K., Delevich, K. M., Marcsisin, M. J., Zhang, W., Sampson, A. R., Gundersen, H. J. G., Lewis, D. A., & Sweet, R. A. (2009) · Brain Research · doi:10.1016/j.brainres.2009.06.019 · Cited by 60 · cited 1×
“The reduced MAP2-IR does not appear to result from reductions in neuron number/density, as this remains unchanged in areas where MAP2-IR loss is profound (Jones et al., 2002; Dorph-Petersen et al., 2009; Somenarain and Jones, 2010).”
BackgroundSelf-citationFöcking, M., Dicker, P., Lopez, L. M., Hryniewiecka, M., Wynne, K., English, J. A., Cagney, G., & Cotter, D. R. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.224 · Cited by 59 · cited 1×
“Decreased MAP2 was also recently observed in bipolar disorder via proteomic analysis of the postsynaptic density (Föcking et al., 2016)—though not, to date, at the whole homogenate level—while it fails to exhibit change at the mRNA level by RNA sequencing (Gandal et al.”
BackgroundItoh, T. J., & Hotani, H. (1994) · Cell Structure and Function · doi:10.1247/csf.19.279 · Cited by 59
A τ Fragment Containing a Repetitive Sequence Induces Bundling of Actin Filaments
Moraga, D. M., Nuñez, P., Garrido, J., & Maccioni, R. B. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03611.x · Cited by 56 · cited 1×
“In addition to MTs, MAP2 can also bind and bundle actin, like Tau (Correas et al., 1990; Moraga et al., 1993; Roger et al., 2004).”
BackgroundInteraction of Microtubule-associated Protein-2 and p63
Farah, C. A., Liazoghli, D., Perreault, S., Desjardins, M., Guimont, A., Antón, A., Lauzon, M., Kreibich, G., Paiement, J. M., & Leclerc, N. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m412304200 · Cited by 56 · cited 2×
“MAP2 creates local dendritic reservoirs of proteins critical to LTP/LTD, including PKA, EB3, RNA particles and polyribosomes (Lim and Halpain, 2000; Nielsen et al., 2002; Ostroff et al., 2002; Angenstein et al., 2005; Farah et al., 2005; Zhong et al., 2009; Kapitein et al., 2011; Sontag et al., 2012; Chirillo et al.,…”
BackgroundLoss of hnRNP K Impairs Synaptic Plasticity in Hippocampal Neurons
Folci, A., Mapelli, L., Sassone, J., Prestori, F., D'Angelo, E. U., Bassani, S., & Passafaro, M. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.0303-14.2014 · Cited by 56 · cited 1×
“Such proteins included FMR1, PCBP1–3, and hnRNPK, which has been previously shown to regulate spine density and LTP as well as mediate the effects of BDNF on dendritic mRNA metabolism and NMDAR function (Folci et al., 2014; Leal et al., 2017).”
BackgroundHuh, J. W., Raghupathi, R., Laurer, H. L., Helfaer, M. A., & Saatman, K. E. (2003) · Journal of Neurotrauma · doi:10.1089/089771503770195821 · Cited by 56
Iwata, M., Shirayama, Y., Ishida, H., & Kawahara, R. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.04.060 · Cited by 54
Angenstein, F., Evans, A. M., Ling, S., Settlage, R. E., Ficarro, S. B., Carrero-Martínez, F. A., Shabanowitz, J., Hunt, D. F., & Greenough, W. T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412742200 · Cited by 52 · cited 1×
“MAP2 creates local dendritic reservoirs of proteins critical to LTP/LTD, including PKA, EB3, RNA particles and polyribosomes (Lim and Halpain, 2000; Nielsen et al., 2002; Ostroff et al., 2002; Angenstein et al., 2005; Farah et al., 2005; Zhong et al., 2009; Kapitein et al., 2011; Sontag et al., 2012; Chirillo et al.,…”
BackgroundChromosome 2 deletion encompassing the MAP2 gene in a patient with autism and Rett‐like features
Pescucci, C., Meloni, I., Bruttini, M., Ariani, F., Longo, I., Mari, F., Canitano, R., Hayek, G., Zappella, M., & Renieri, A. (2003) · Clinical Genetics · doi:10.1046/j.1399-0004.2003.00176.x · Cited by 52 · cited 2×
“Moreover, case study reports of rare 2q34 deletions—which encompass the MAP2 gene—have described autism-like outcomes (Pescucci et al., 2003; Westphal et al., 2018).”
BackgroundMeichsner, M., Doll, T., Reddy, D., Weisshaar, B., & Matus, A. I. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90581-y · Cited by 51 · cited 1×
“, 1984), although MAP2C can be detected in axons (Meichsner et al., 1993), and MAP2D may be expressed in some glia (Doll et al.”
BackgroundEffects and mechanisms of melatonin on neural differentiation of induced pluripotent stem cells
Shu, T., Wu, T., Pang, M., Liu, C., Wang, X., Wang, J., Liu, B., & Rong, L. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.04.108 · Cited by 51 · cited 1×
“Melatonin increases neurite length, cellular MT content and MAP2 expression in a variety of contexts (Meléndez et al., 1996; Prieto-Gómez et al., 2008; Shu et al., 2016).”
BackgroundAlterations in hippocampal non-phosphorylated MAP2 protein expression in schizophrenia
Cotter, D., Kerwin, R. W., Doshi, B., Martin, C. S., & Everall, I. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00575-1 · Cited by 50
Kühn, J., Meißner, C., & Oehmichen, M. (2005) · Acta Neuropathologica · doi:10.1007/s00401-005-1090-9 · Cited by 49
Experience-Dependent Modifications in MAP2 Phosphorylation in Rat Olfactory Bulb
Philpot, B. D., Lim, J. H., Halpain, S., & Brunjes, P. C. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-24-09596.1997 · Cited by 47
Jalava, N., Lopez‐Picon, F. R., Kukko‐Lukjanov, T., & Holopainen, I. E. (2006) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2006.12.001 · Cited by 46
Proteomic Investigations of Autism Brain Identify Known and Novel Pathogenetic Processes
Abraham, J. R., Szoko, N., Barnard, J., Rubin, R. A., Schlatzer, D., Lundberg, K. C., Li, X., & Natowicz, M. R. (2019) · Scientific Reports · doi:10.1038/s41598-019-49533-y · Cited by 45 · cited 1×
“Interestingly, a significant change in MAP2 expression was noted in a recent proteomic analysis of autism (though this did not survive correction for false discovery rate; Abraham et al., 2019).”
BackgroundKomulainen, E., Zdrojewska, J., Freemantle, E., Mohammad, H., Kulesskaya, N., Deshpande, P., Marchisella, F., Mysore, R., Hollós, P., Michelsen, K. A., et al. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00272 · Cited by 44 · cited 1×
“JNK1 represents a notable exception to the general principle of MAP2 phosphorylation in that its phosphorylation of several proline-rich domain residues (T1619, T1622, and T1625) increases—rather than decreases—the protein’s binding to MTs, as well as enhances dendritic arborization (Komulainen et al., 2014).”
BackgroundJuvenile and mature MAP2 isoforms induce distinct patterns of process outgrowth.
Leclerc, N., Baas, P. W., Garner, C. C., & Kosik, K. S. (1996) · Molecular Biology of the Cell · doi:10.1091/mbc.7.3.443 · Cited by 43 · cited 1×
“Indeed, expression of MAP2 has repeatedly been shown to induce process formation in multiple heterologous cell lines (Edson et al., 1993; Leclerc et al., 1996).”
BackgroundMages, B., Fuhs, T., Aleithe, S., Blietz, A., Hobusch, C., Härtig, W., Schob, S., Krueger, M., & Michalski, D. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02372-3 · Cited by 42 · cited 1×
“MAP2 expression is significantly and consistently reduced early after induction of ischemia in both rodents (Dawson and Hallenbeck, 1996; Mages et al., 2021) and humans (Kühn et al.”
BackgroundMAP2 is differentially phosphorylated in schizophrenia, altering its function
Grubisha, M. J., Sun, X., MacDonald, M. L., Garver, M. E., Sun, Z., Paris, K. A., Patel, D. S., DeGiosio, R. A., Lewis, D. A., Yates, N. A., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01034-z · Cited by 42 · cited 11×
“We have found that this association has functional consequence, as overexpressed MAP2C inhibits protein synthesis in HEK cells (Grubisha et al., 2021).”
BackgroundResultInfluentialSelf-citationMcKinney, B. C., MacDonald, M. L., Newman, J. T., Shelton, M. A., DeGiosio, R. A., Kelly, R. M., Fish, K. N., Sampson, A. R., Lewis, D. A., & Sweet, R. A. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0350-7 · Cited by 41 · cited 4×
“Additionally, MAP2-IR loss statistically mediates dendritic spine loss in primary auditory cortex of subjects with schizophrenia (McKinney et al., 2019).”
BackgroundInfluentialSelf-citationCommon variants in CACNA1C and MDD susceptibility: A comprehensive meta‐analysis
Rao, S., Yao, Y., Zheng, C., Ryan, J., Mao, C., Zhang, F., Meyre, D., & Xu, Q. (2016) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32466 · Cited by 40
Beharry, C., Alaniz, M. E., & Alonso, A. D. C. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-130617 · Cited by 39 · cited 1×
“Phosphomimicry of Tau can lead to learning and memory deficits in Drosophila and mice (Beharry et al., 2013; Di et al., 2016) MAP2 knockdown can lead to impairments in LTP and dendritic outgrowth, which are implicated in neurodevelopmental and neurodegenerative disorder (Kim et al.”
BackgroundMAP2 Splicing is Altered in Huntington's Disease
Cabrera, J. R., & Lucas, J. J. (2016) · Brain Pathology · doi:10.1111/bpa.12387 · Cited by 38 · cited 1×
“In contrast, in Huntington’s Disease, MAP2 splicing is altered, leading to an imbalance between high and low molecular weight MAP2 forms that is thought to contribute to the dendritic atrophy which characterizes the disorder (Cabrera and Lucas, 2017).”
BackgroundFunctional analysis of the MAP2 repeat domain
Ludin, B., Ashbridge, K. R., Fünfschilling, U., & Matus, A. I. (1996) · Journal of Cell Science · doi:10.1242/jcs.109.1.91 · Cited by 38
Pregnenolone for cognition and mood in dual diagnosis patients
Osuji, I. J., Vera‐Bolanos, E., Carmody, T. J., & Brown, E. S. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2009.09.006 · Cited by 37 · cited 1×
“For instance, pregnenolone—a neurosteroid with potential antidepressant and neuroprotective properties (Osuji et al., 2010; Marx et al., 2011, 2014)—enhances neurite growth by binding directly to MAP2 to simulate tubulin polymerization (Murakami et al.”
BackgroundYamauchi, P. S., & Purich, D. L. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.1107 · Cited by 36
Yamauchi, P. S., & Purich, D. L. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61512-1 · Cited by 36
Saia-Cereda, V. M., Cassoli, J. S., Schmitt, A., Falkai, P., & Martins‐de‐Souza, D. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.03.022 · Cited by 35
Effect of melatonin on β-tubulin and MAP2 expression in NIE-115 cells
Meléndez-Zajgla, J., Maldonado, V., & Ortega, A. (1996) · Neurochemical Research · doi:10.1007/bf02527721 · Cited by 35
Mitsuyama, F., Niimi, G., Katō, K., Hirosawa, K., Mikoshiba, K., Okuya, M., Karagiozov, K. L., Kato, Y., Kanno, T., Sanoe, H., et al. (2008) · PubMed · Cited by 35
A comparative study of MAP2 immunostaining in areas 9 and 17 in schizophrenia and Huntington chorea
Somenarain, L., & Jones, L. B. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.12.006 · Cited by 31 · cited 3×
“The loss of MAP2 protein was accompanied by a substantial loss of MAP2-IR in the region, complimenting prior work showing reduced MAP2-IR in Brodmann area 9 of Huntington’s subjects (Somenarain and Jones, 2010).”
BackgroundResultAbdalla, R. N., Ansari, S. A., Hurley, M. C., Attarian, H. P., Fargen, K. M., Hirsch, J. A., Cantrell, D. R., Curl, P. K., Daves, P. R., & Shaibani, A. (2022) · American Journal of Neuroradiology · doi:10.3174/ajnr.a7606 · Cited by 31 · cited 1×
“, 2021) and humans (Kühn et al., 2005), a loss which is thought to occur through calpain-mediated proteolysis (Pettigrew et al.”
BackgroundLlansola, M., Sáez, R., & Felipo, V. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01497.x · Cited by 30 · cited 1×
“This activity-dependent phosphorylation appears to be mediated at least in part by the Ras-MAPK pathway (Llansola et al., 2001; Kim et al., 2020), though to our knowledge, activity-dependent phosphosites of MAP2 have not yet been confirmed.”
BackgroundXie, C., Miyasaka, T., Yoshimura, S., Hatsuta, H., Yoshina, S., Kage-Nakadai, E., Mitani, S., Murayama, S., & Ihara, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089796 · Cited by 28
Effects of long-term treatment with desipramine on microtubule proteins in rat cerebral cortex
Miyamoto, S., Asakura, M., Sasuga, Y., Osada, K., Bodaiji, N., Imafuku, J., & Aoba, A. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01140-0 · Cited by 28
Altered subicular MAP2 immunoreactivity in schizophrenia.
Rosoklija, G. B., Keilp, J. G., Toomayan, G. A., Mancevski, B., Haroutunian, V., Liu, D., Malespina, D., Hays, A. P., Sadiq, S. A., Latov, N., et al. (2005) · PubMed · Cited by 28
Guo, Y., Gong, H.-S., Zhang, J., Xie, W.-L., Tian, C., Chen, C., Shi, Q., Wang, S.-B., Xu, Y., Zhang, B., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030163 · Cited by 27
Pérez, J., Mori, S., Caivano, M., Popoli, M., Zanardi, R., Smeraldi, E., & Racagnib, G. (1995) · European Neuropsychopharmacology · doi:10.1016/0924-977x(95)00024-j · Cited by 25 · cited 1×
“, 2006), while treatments with fluvoxamine, desipramine, maprotiline, and citalopram increase MAP2 phosphorylation (as assessed using phosphospecific antibodies or 32P incorporation), in turn suppressing tubulin polymerization (Miyamoto et al., 1995, 1997; Perez et al., 1995).”
BackgroundPrieto-Gómez, B., Velázquez-Paniagua, M., Olivos-Cisneros, L., Reyes-Vázquez, C., Jiménez-Trejo, F. J., Reyes, M. E., Mendoza‐Torreblanca, J. G., & Gutiérrez‐Ospina, G. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.10.041 · Cited by 24 · cited 1×
“Melatonin increases neurite length, cellular MT content and MAP2 expression in a variety of contexts (Meléndez et al., 1996; Prieto-Gómez et al., 2008; Shu et al., 2016).”
BackgroundMicrotubule-associated protein MAP2 expression in olfactory bulb in schizophrenia
Rioux, L., Ruscheinsky, D. D., & Arnold, S. E. (2004) · Psychiatry Research · doi:10.1016/j.psychres.2004.05.022 · Cited by 23
The projection domain of MAP2b regulates microtubule protrusion and process formation in Sf9 cells
Bélanger, D., Farah, C. A., Nguyen, M. D., Lauzon, M., Cornibert, S., & Leclerc, N. M. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.7.1523 · Cited by 23
Conserved Lysine Acetylation within the Microtubule-Binding Domain Regulates MAP2/Tau Family Members
Hwang, A. W., Trzeciakiewicz, H., Friedmann, D., Yuan, C., Marmorstein, R., Lee, V. M. ‐., & Cohen, T. J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0168913 · Cited by 22
Jansen, S., Melková, K., Trošanová, Z., Hanáková, K., Zachrdla, M., Nováček, J., Župa, E., Zdráhal, Z., Hritz, J., & Žídek, L. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.771097 · Cited by 21
Microtubule-Associated Type II Protein Kinase A Is Important for Neurite Elongation
Huang, Y., Kao, J.-W., Tseng, D. T., Chen, W.-S., Chiang, M.-H., & Hwang, E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073890 · Cited by 21
Sarkar, T., Mitra, G., Gupta, S., Manna, T. K., Poddar, A., Panda, D., Das, K. P., & Bhattacharyya, B. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2004.04053.x · Cited by 18
Westphal, D. S., Andres, S., Makowski, C. C., Meitinger, T., & Hoefele, J. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00099 · Cited by 17
DeGiosio, R. A., Kelly, R. M., DeDionisio, A. M., Newman, J. T., Fish, K. N., Sampson, A. R., Lewis, D. A., & Sweet, R. A. (2019) · Schizophrenia · doi:10.1038/s41537-019-0081-0 · Cited by 17 · cited 17×
“In summary, aberrant MAP2 phosphorylation in schizophrenia may both underlie the profound reductions in MAP2-IR observed Frontiers in Molecular Neuroscience 08 frontiersin.org postmortem and have direct consequences for neuronal structure and function.”
BackgroundInfluentialSelf-citationAkulinin, V. A., & Dahlström, A. B. (2003) · Neurochemical Research · doi:10.1023/a:1022401922669 · Cited by 17 · cited 1×
“Despite clear evidence that disruptions to MAP2 expression and/or modification can lead to changes in dendritic and synaptic structure and function (Sharma et al., 1994; Ozer and Halpain, 2000; Harada et al., 2002; Akulinin and Dahlstrom, 2003; Dehmelt et al., 2003; Huang et al., 2013; Kim et al., 2020; Grubisha et al…”
BackgroundStearns, M. E., & Brown, D. L. (1979) · FEBS Letters · doi:10.1016/0014-5793(79)81285-5 · Cited by 16 · cited 1×
“It has been long accepted that the primary function of MAP2, like Tau, is to bind MTs to increase their polymerization and bundling (Herzog and Weber, 1978; Stearns and Brown, 1979; Lewis et al., 1989).”
BackgroundMitra, G., Gupta, S., Poddar, A., & Bhattacharyya, B. (2015) · Biophysical Chemistry · doi:10.1016/j.bpc.2015.06.003 · Cited by 15 · cited 2×
“Of particular interest is the association MAP2 shares with Tau; MAP2 prevents the arachidonic acid-induced aggregation of Tau protein (Mitra et al., 2015), although the mechanism thereof is still unclear.”
BackgroundEarly bioenergetic and autophagy impairments at the Parkinson’s disease synapse
Prieto, G. A., & Cotman, C. W. (2022) · Brain · doi:10.1093/brain/awac191 · Cited by 10
The RNA ‐binding protein MARTA 2 regulates dendritic targeting of MAP 2 mRNA s in rat neurons
Zivraj, K. H., Rehbein, M., Ölschläger‐Schütt, J., Schob, C., Falley, K., Buck, F., Schweizer, M., Schepis, A., Kremmer, E., Richter, D., et al. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12079 · Cited by 10
Sun, F., & Handel, M. A. (2011) · Genes · doi:10.3390/genes2010021 · Cited by 9
Jansen, S., Melková, K., Trošanová, Z., Hanáková, K., Zachrdla, M., Nováček, J., Župa, E., Zdráhal, Z., Hritz, J., & Žídek, L. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.a116.771097 · Cited by 8
SMN loss dysregulates microtubule-associated proteins in spinal muscular atrophy model
Zobaroğlu-Özer, P., Koyunoğlu, D., Son, Ç. D., Erdem‐Yurter, H., & Bora, G. (2022) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2022.103725 · Cited by 8 · cited 1×
“Further, one recent study has demonstrated the downregulation of MAP2 protein in SMN-deficient motor neuron-like cells modeling spinal muscular atrophy, which the authors speculate may also be due to calpain hyperactivity (Özer et al., 2022).”
Result
Cited by
Mandal, G., Kirkpatrick, M., Alboni, S., Mariani, N., Pariante, C. M., & Borsini, A. (2024) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyae041 · Cited by 15
“To measure hippocampal neurogenesis in vitro, we use markers to determine differentiation into immature (doublecortin [DCX]) (Gómez-Climent et al., 2008) and mature (microtubule-associated protein 2 [MAP2]) neurons (DeGiosio et al., 2022).”
Metadata
- Authors
- DeGiosio, R. A., Grubisha, M. J., MacDonald, M. L., McKinney, B. C., Camacho, C. J., & Sweet, R. A.
- Venue
- Frontiers in Molecular Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2022-09-16
- Volume
- 15
- Pages
- 974890-974890
- ISSN
- 1662-5099 (ISSN-L)
- OpenAlex
- W4296175720
- Cited by
- 162
- References
- 179
- FWCI
- 16.30
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.